Save the date: WFH 2026 World Congress

Save the date: WFH 2026 World Congress

The WFH and the Hemophilia Society of Malaysia are proud to invite you to the WFH 2026 World Congress, taking place April 19 to 22, 2026, in Kuala Lumpur, Malaysia.

Also available in: Français Español

As the largest and most comprehensive international event on bleeding disorders in 2026, the WFH 2026 World Congress will bring together healthcare professionals, people with bleeding disorders (PWBDs), national member organizations (NMOs), researchers, advocates, and industry leaders from around the world.

The WFH 2026 World Congress will include over 80 hours of continuing educational sessions across the Medical and People with Bleeding Disorders (PWBD) tracks, as well as six professional development tracks: Nursing, Dental, Laboratory Sciences, Psychosocial, Musculoskeletal (MSK) and Women and Girls with Bleeding Disorders (WGBD). Participants can expect to be treated to a world-class program that will cover the very latest medical and multidisciplinary developments. It will feature world-class plenary and session speakers, interactive sessions, workshops, panel discussions and innovative industry symposia. And, of course, a rich social calendar will help participants get the most out of their time in Kuala Lumpur.

This in-person event will be an unmatched opportunity to connect, learn, and collaborate with the global bleeding disorders community. Stay tuned—registration opens soon!

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.